PLRX
Price
$12.14
Change
-$0.48 (-3.80%)
Updated
Sep 20 closing price
45 days until earnings call
RCKT
Price
$20.17
Change
-$1.19 (-5.57%)
Updated
Sep 20 closing price
46 days until earnings call
Ad is loading...

PLRX vs RCKT

Header iconPLRX vs RCKT Comparison
Open Charts PLRX vs RCKTBanner chart's image
Pliant Therapeutics
Price$12.14
Change-$0.48 (-3.80%)
Volume$512.43K
CapitalizationN/A
Rocket Pharmaceuticals
Price$20.17
Change-$1.19 (-5.57%)
Volume$1.47M
CapitalizationN/A
View a ticker or compare two or three
PLRX vs RCKT Comparison Chart
Loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
PLRX vs. RCKT commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRX is a Sell and RCKT is a Sell.

COMPARISON
Comparison
Sep 21, 2024
Stock price -- (PLRX: $12.15 vs. RCKT: $20.17)
Brand notoriety: PLRX and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLRX: 82% vs. RCKT: 88%
Market capitalization -- PLRX: $767.31M vs. RCKT: $1.83B
PLRX [@Biotechnology] is valued at $767.31M. RCKT’s [@Biotechnology] market capitalization is $1.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $595.57B to $0. The average market capitalization across the [@Biotechnology] industry is $3.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLRX’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 0 green FA rating(s).

  • PLRX’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 0 green, 5 red.
According to our system of comparison, RCKT is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLRX’s TA Score shows that 3 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • PLRX’s TA Score: 3 bullish, 6 bearish.
  • RCKT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RCKT is a better buy in the short-term than PLRX.

Price Growth

PLRX (@Biotechnology) experienced а +1.25% price change this week, while RCKT (@Biotechnology) price change was +2.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.72%. For the same industry, the average monthly price growth was +1.90%, and the average quarterly price growth was -0.55%.

Reported Earning Dates

PLRX is expected to report earnings on Nov 05, 2024.

RCKT is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (+0.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($1.84B) has a higher market cap than PLRX($767M). RCKT (-32.699) and PLRX (-32.910) have similar YTD gains . PLRX has higher annual earnings (EBITDA): -181.41M vs. RCKT (-243.06M). PLRX has more cash in the bank: 437M vs. RCKT (279M). RCKT has less debt than PLRX: RCKT (25.8M) vs PLRX (60.2M). PLRX (0) and RCKT (0) have equivalent revenues.
PLRXRCKTPLRX / RCKT
Capitalization767M1.84B42%
EBITDA-181.41M-243.06M75%
Gain YTD-32.910-32.699101%
P/E RatioN/AN/A-
Revenue00-
Total Cash437M279M157%
Total Debt60.2M25.8M233%
FUNDAMENTALS RATINGS
RCKT: Fundamental Ratings
RCKT
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
5

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PLRXRCKT
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 17 days ago
78%
Bullish Trend 23 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 10 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRBCX13.24N/A
N/A
BlackRock Tactical Opportunities Inv C
VBPIX19.58N/A
N/A
Vanguard Baillie GiffordGlbPstvImpStkInv
PPUPX19.26-0.05
-0.26%
Principal LargeCap Growth I R5
NRFNX12.08-0.07
-0.58%
Natixis AEW Global Focused Real Estate N
BRXCX13.73-0.10
-0.72%
MFS Blended Research Intl Eq C

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-3.72%
NTLA - PLRX
54%
Loosely correlated
-4.58%
BEAM - PLRX
52%
Loosely correlated
-1.42%
PRME - PLRX
49%
Loosely correlated
-2.05%
RCUS - PLRX
49%
Loosely correlated
-1.90%
RCKT - PLRX
49%
Loosely correlated
-5.57%
More

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with RYTM. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then RYTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
-5.57%
RYTM - RCKT
53%
Loosely correlated
-3.21%
FOLD - RCKT
53%
Loosely correlated
+2.64%
RXRX - RCKT
53%
Loosely correlated
-1.87%
AXON - RCKT
52%
Loosely correlated
+0.96%
BEAM - RCKT
51%
Loosely correlated
-1.42%
More